Treatment of canine lymphoma with COPLA/LVP

Seventy-five dogs with cytopathologically or histopathologically confirmed lymphoma received L-asparaginase, vincristine, cyclophosphamide, prednisone, and doxorubicin (COPLA) induction followed by chlorambucil, vincristine, and prednisone (LVP) maintenance between January 1994 and June 1997. Toxicity was evaluated using the National Cancer Institute (NCI) toxicity criteria. Age, weight, sex, and response were evaluated for prognostic significance against first remission duration. A complete response (CR) was obtained in 61 (80%) dogs, a partial response (PR) was obtained in nine (12%) dogs, and no response (NR) was obtained in five (8%) dogs. The median first remission duration was 25 weeks, with 17% and 5% of the dogs in remission at one and two years, respectively. Observed toxicity was low, with 84% of dogs given an NCI score of 1 or 2. Median survival time for dogs achieving CR was 36 weeks versus four weeks for those achieving PR or NR.

This article has been cited by other articles:

				J. D. Frank, S. B. Reimer, P. H. Kass, and M. Kiupel Clinical Outcomes of 30 Cases (1997 2004) of Canine Gastrointestinal Lymphoma J. Am. Anim. Hosp. Assoc., November 1, 2007; 43(6): 313 - 321. [Abstract] [Full Text] [PDF]

				C. I. Kaiser, J. L. Fidel, M. Roos, and B. Kaser-Hotz Reevaluation of the University of Wisconsin 2-Year Protocol for Treating Canine Lymphosarcoma J. Am. Anim. Hosp. Assoc., March 1, 2007; 43(2): 85 - 92. [Abstract] [Full Text] [PDF]

				C. B. Greenberg, P. A. Boria, A. Borgatti-Jeffreys, R. E. Raskin, and M. D. Lucroy Phase II Clinical Trial of Combination Chemotherapy With Dexamethasone for Lymphoma in Dogs J. Am. Anim. Hosp. Assoc., January 1, 2007; 43(1): 27 - 32. [Abstract] [Full Text] [PDF]

				V. E. Valli, W. Vernau, L.-P de Lorimier, P. S. Graham, and P. F. Moore Canine Indolent Nodular Lymphoma Vet. Pathol., May 1, 2006; 43(3): 241 - 256. [Abstract] [Full Text] [PDF]

				A. B. Jeffreys, D. W. Knapp, W. W. Carlton, R. M. Thomas, P. L. Bonney, A. deGortari, and M. D. Lucroy Influence of Asparaginase on a Combination Chemotherapy Protocol for Canine Multicentric Lymphoma J. Am. Anim. Hosp. Assoc., July 1, 2005; 41(4): 221 - 226. [Abstract] [Full Text] [PDF]

				S. R. Ricci Lucas, B. M. Pereira Coelho, M. L. Marquezi, M. L. Franchini, S. I. Miyashiro, and D. H. de Benedetto Pozzi Carmustine, Vincristine, and Prednisone in the Treatment of Canine Lymphosarcoma J. Am. Anim. Hosp. Assoc., July 1, 2004; 40(4): 292 - 299. [Abstract] [Full Text] [PDF]

				N. Benitah, L.-P. de Lorimier, M. Gaspar, and B. E. Kitchell Chlorambucil-Induced Myoclonus in a Cat With Lymphoma J. Am. Anim. Hosp. Assoc., May 1, 2003; 39(3): 283 - 287. [Abstract] [Full Text] [PDF]